May 2008
Seminar by Dr. Roger Abey with AstraZeneca on "Development of vandetanib (ZactimaTM) and cediranib (RecentinTM) as anti-cancer agents".
January 2008
Dr. Richard Goldberg,
Director of Oncology Services and Associate Director
of the Lineberger Comprehensive Cancer Center, was the keynote speaker at the SCCA Quarterly meeting sponsored by the CCCR.
October 2007
Congratulations to
Drs. Prakash Nagarkatti,
Mitizi Nagarkatti, and Lorne Hofseth who recieved a $6 million dollar NIH grant to establish research center focused on complementary, alternative medicine.
|